G94S (p.Gly94Ser) variant of KRT5 (Keratin, type II cytoskeletal 5)

G94S (p.Gly94Ser) in KRT5 (Keratin, type II cytoskeletal 5) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as benign/likely benign in the context of not provided. The available variant effect predictions contribute to a CATVariant prioritization score of 0.18 / 1. The record also includes population frequency data and structural context.

G94S (p.Gly94Ser) variant details